Yokoyama T, Ikedou Y, Kido F, Tanoue S, Tashiro K, Ninomiya H, Rikimaru T, Kajiki A, Takamoto M, Ishibashi T, Oizumi K
High Standard Emergency and Critical Care Medical Center, Kurume University School of Medicine.
Nihon Kokyuki Gakkai Zasshi. 1998 Oct;36(10):851-6.
We studied the levels of carbohydrate antigen (CA 19-9, SLX, CA 50, Span-1, and Dupan-2) in serum, bronchoalveolar lavage fluid, and tissue from patients with benign bronchopulmonary disease. Patients had bronchiectasis, healed pulmonary tuberculosis, pulmonary fibrosis, or other diseases. Bronchoalveolar lavage fluid levels and immunohistochemical findings for lung tissue samples, in the absence of digestive and other diseases, suggested that elevated serum sialylated Lewis(A) (CA 19-9, CA 50, and Span-1) and Lewis(X) (SLX) antigen in patients with benign broncho-pulmonary disease are due to marked production of sialylated carbohydrate antigen in respiratory bronchioles. Common features of patients with benign bronchopulmonary disease include elevated serum carbohydrate antigen levels and bronchiectasis.
我们研究了良性支气管肺部疾病患者血清、支气管肺泡灌洗液及组织中糖类抗原(CA 19-9、SLX、CA 50、Span-1和Dupan-2)的水平。患者患有支气管扩张症、愈合的肺结核、肺纤维化或其他疾病。在不存在消化系统及其他疾病的情况下,支气管肺泡灌洗液水平及肺组织样本的免疫组化结果表明,良性支气管肺部疾病患者血清中唾液酸化Lewis(A)(CA 19-9、CA 50和Span-1)及Lewis(X)(SLX)抗原升高是由于呼吸性细支气管中唾液酸化糖类抗原的大量产生。良性支气管肺部疾病患者的共同特征包括血清糖类抗原水平升高及支气管扩张症。